BioNexus Gene Lab Corp. (BGLC) Operating cash flow 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2018: -$274,080 → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | +12.2% |
| FY2024 | -$2.1M | -14.9% |
| FY2023 | -$1.8M | -430.2% |
| FY2022 | $551,822 | +5923.6% |
| FY2021 | $9,161 | -98.3% |
| FY2020 | $552,680 | +354.4% |
| FY2019 | -$217,273 | +20.7% |
| FY2018 | -$274,080 | — |
Source: SEC XBRL filings · For reference only · Not investment advice